Nonablative allogeneic stem cell transplantation for chronic lymphocytic leukemia: impact of rituximab on immunomodulation and survival

Podobne zapisy

• Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results
  od: Narin Apisarnthanarax, i wsp.
  Wydane: (2003)
• Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab
  od: Issa F. Khouri, i wsp.
  Wydane: (2008)
• Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation
  od: Daniel R. Couriel, i wsp.
  Wydane: (2004)
• Poor hematopoietic stem cell mobilizers: A single institution study of incidence and risk factors in patients with recurrent or relapsed lymphoma
  od: Hosing, Chitra, i wsp.
  Wydane: (2009)
• Impairment of Filgrastim-Induced Stem Cell Mobilization after Prior Lenalidomide in Patients with Multiple Myeloma
  od: Popat, Uday, i wsp.
  Wydane: (2009)